Petros Pharmaceuticals, Inc. - Common Stock, $0.0001 par value (PTPI)

CUSIP: 71678J209

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / Common Stock, $0.0001 par value
Shares outstanding
25,296,136
Total 13F shares
99,607
Share change
-2,506
Total reported value
$170,571
Price per share
$1.73
Number of holders
14
Value change
-$21,147
Number of buys
2
Number of sells
5

Security key

71678J209

Report period

Q3 2023

Institutions

14

Top holders

10

Ownership snapshot

Top shareholders of PTPI - Petros Pharmaceuticals, Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
VANGUARD GROUP INC
13D/G signal
Evidence rows
16
Latest as of
30 Jun 2023
13F 3/4/5 Lead comparable stake: 0.13% Showing first 8 of 16 holder rows. Open remaining rows
Holder Evidence Ownership % Position 12M Net Δ As of
VANGUARD GROUP INC
13F
Company
13F
0.13%
$64,576
31,811 shares
30 Jun 2023
Schonfeld Strategic Advisors LLC
13F
Company
13F
0.09%
$47,096
23,200 shares
30 Jun 2023
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
0.07%
$34,000
16,779 shares
30 Jun 2023
BlackRock Finance, Inc.
13F
Company
13F
0.07%
$33,515
16,510 shares
30 Jun 2023
BANK OF MONTREAL /CAN/
13F
Company
13F
0.04%
$27,400
10,000 shares
30 Jun 2023
Tower Research Capital LLC (TRC)
13F
Company
13F
0.01%
$5,168
2,546 shares
30 Jun 2023
EMFO, LLC
13F
Company
13F
0%
$2,030
1,000 shares
30 Jun 2023
NFSG Corp
13F
Company
13F
0%
$244
120 shares
30 Jun 2023
Show 8 additional holder rows in the full holder list
Holder Evidence Ownership % Position 12M Net Δ As of
GROUP ONE TRADING LLC
13F
Company
13F
0%
$160
79 shares
30 Jun 2023
MORGAN STANLEY
13F
Company
13F
0%
$39
19 shares
30 Jun 2023
BANK OF AMERICA CORP /DE/
13F
Company
13F
0%
$28
14 shares
30 Jun 2023
OSAIC HOLDINGS, INC.
13F
Company
13F
0%
$28
14 shares
30 Jun 2023
WELLS FARGO & COMPANY/MN
13F
Company
13F
0%
$22
11 shares
30 Jun 2023
FIRST MANHATTAN CO. LLC.
13F
Company
13F
0%
$20
10 shares
30 Jun 2023
John D. Shulman
3/4/5
Director, 10%+ Owner
mixed-class rows
$19,563,156
5,812,873 shares
mixed-class rows
22 Dec 2021
Andrew Gesek
3/4/5
President, Timm Medical
class O/S missing
75,000 shares
11 May 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
14
Shares
99,607
Rows loaded
14
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. An asterisk next to the price means the price is likely invalid.

Compare Q3 2023 vs Q2 2023 Across Filers

Q2 2023 holders
14
Q3 2023 holders
14
Holder diff
0
Investor Q2 2023 Shares Q3 2023 Shares Share Diff Share Chg % Q2 2023 value Q3 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .